Skip to content 
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany. more
| Time Frame | BAYRY | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 1.43% | -2.12% | -0.38% |
| 1-Month Return | -12.98% | -6.51% | -4.3% |
| 3-Month Return | 7.49% | -5.6% | -3.65% |
| 6-Month Return | 38.48% | 7.3% | -1.3% |
| 1-Year Return | 71.32% | -0.27% | 16.65% |
| 3-Year Return | -25.77% | 15.48% | 67.09% |
| 5-Year Return | -29.86% | 26.75% | 67.58% |
| 10-Year Return | -60.76% | 118.07% | 223.2% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 44.08B | 50.74B | 47.64B | 46.61B | 45.58B | [{"date":"2021-12-31","value":86.88,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.89,"profit":true},{"date":"2024-12-31","value":91.85,"profit":true},{"date":"2025-12-31","value":89.82,"profit":true}] |
| Cost of Revenue | 16.82B | 19.87B | 19.75B | 21.27B | 18.80B | [{"date":"2021-12-31","value":79.06,"profit":true},{"date":"2022-12-31","value":93.42,"profit":true},{"date":"2023-12-31","value":92.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":88.37,"profit":true}] |
| Gross Profit | 27.27B | 30.87B | 27.89B | 25.34B | 26.78B | [{"date":"2021-12-31","value":88.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.35,"profit":true},{"date":"2024-12-31","value":82.08,"profit":true},{"date":"2025-12-31","value":86.75,"profit":true}] |
| Gross Margin | 61.85% | 60.84% | 58.54% | 54.36% | 58.76% | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.36,"profit":true},{"date":"2023-12-31","value":94.65,"profit":true},{"date":"2024-12-31","value":87.89,"profit":true},{"date":"2025-12-31","value":94.99,"profit":true}] |
| Operating Expenses | 20.36B | 23.54B | 27.89B | 22.01B | 39.44B | [{"date":"2021-12-31","value":51.62,"profit":true},{"date":"2022-12-31","value":59.68,"profit":true},{"date":"2023-12-31","value":70.72,"profit":true},{"date":"2024-12-31","value":55.81,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | 6.97B | 6.26B | (150.00M) | 3.33B | 6.14B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.81,"profit":true},{"date":"2023-12-31","value":-2.15,"profit":false},{"date":"2024-12-31","value":47.7,"profit":true},{"date":"2025-12-31","value":88.01,"profit":true}] |
| Total Non-Operating Income/Expense | 1.27B | (5.57B) | (3.08B) | (7.56B) | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-439.65,"profit":false},{"date":"2023-12-31","value":-243.44,"profit":false},{"date":"2024-12-31","value":-597,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 2.05B | 4.67B | (1.62B) | (2.33B) | (3.13B) | [{"date":"2021-12-31","value":43.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-34.71,"profit":false},{"date":"2024-12-31","value":-49.98,"profit":false},{"date":"2025-12-31","value":-67,"profit":false}] |
| Income Taxes | 1.02B | 504.00M | 1.32B | 212.00M | - | [{"date":"2021-12-31","value":77.52,"profit":true},{"date":"2022-12-31","value":38.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":16.05,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income After Taxes | 1.02B | 4.17B | (2.94B) | (2.55B) | - | [{"date":"2021-12-31","value":24.53,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-70.62,"profit":false},{"date":"2024-12-31","value":-61.11,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 1.02B | 4.17B | (2.94B) | (2.55B) | (3.60B) | [{"date":"2021-12-31","value":24.53,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-70.62,"profit":false},{"date":"2024-12-31","value":-61.11,"profit":false},{"date":"2025-12-31","value":-86.29,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 1.00B | 4.15B | (2.94B) | (2.55B) | (3.62B) | [{"date":"2021-12-31","value":24.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-70.87,"profit":false},{"date":"2024-12-31","value":-61.49,"profit":false},{"date":"2025-12-31","value":-87.23,"profit":false}] |
| EPS (Diluted) | 2.84 | 2.13 | 1.72 | 1.36 | 0.84 | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.95,"profit":true},{"date":"2023-12-31","value":60.52,"profit":true},{"date":"2024-12-31","value":47.86,"profit":true},{"date":"2025-12-31","value":29.48,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| BAYRY | |
|---|---|
| Current Ratio | 1.01 |
| Quick Ratio | 0.63 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| BAYRY | |
|---|---|
| ROA (LTM) | 2.97% |
| ROE (LTM) | -12.37% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| BAYRY | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.75 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.25 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| BAYRY | |
|---|---|
| Trailing PE | NM |
| Forward PE | 8.70 |
| P/S (TTM) | 0.97 |
| P/B | 1.52 |
| Price/FCF | 13 |
| EV/R | 1.49 |
| EV/Ebitda | 35.45 |
| PEG | 4.61 |
Bayer AG PK (BAYRY) share price today is $10.97
Yes, Indians can buy shares of Bayer AG PK (BAYRY) on Vested. To buy
Yes, you can purchase fractional shares of Bayer AG PK (BAYRY) via the Vested app. You can start investing in Bayer AG PK (BAYRY) with a minimum investment of $1.
You can invest in shares of Bayer AG PK (BAYRY) via Vested in three simple steps:
The 52-week high price of Bayer AG PK (BAYRY) is $14.85. The 52-week low price of Bayer AG PK (BAYRY) is $5.35.
The price-to-earnings (P/E) ratio of Bayer AG PK (BAYRY) is
The price-to-book (P/B) ratio of Bayer AG PK (BAYRY) is 1.52
The dividend yield of Bayer AG PK (BAYRY) is 0.96%
The market capitalization of Bayer AG PK (BAYRY) is $44.07B
The stock symbol (or ticker) of Bayer AG PK is BAYRY
Consider the share price of Bayer AG PK as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Bayer AG PK has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Bayer AG PK shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Bayer AG PK stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Bayer AG PK and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Bayer AG PK stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
